✦ LIBER ✦

Angiotensin-converting enzyme therapy and the risk of contrast-induced nephropathy after coronary angiography and percutaneous coronary intervention

✍ Scribed by Kalpesh Patel; Peter Danyi; Antonio Abbate; Ion S. Jovin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Angiotensin-converting enzyme inhibitors

✍ Kalpesh Patel; Christopher A. King; Ion S. Jovin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 118 KB

A simple risk score for prediction of co

✍ R. Mehran; E.D. Aymong; E. Nikolsky 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 34 KB

A simple risk score for prediction of co

✍ Roxana Mehran; Eve D. Aymong; Eugenia Nikolsky; Zoran Lasic; Ioannis Iakovou; Ma 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Abbreviated Dosing of N-Acetylcysteine P

✍ ANTHONY OCHOA; GREGORY PELLIZZON; SRINIVAS ADDALA; CINDY GRINES; YELENA ISAYENKO 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Contrast-Induced nephropathy after percu

✍ George Dangas; Ioannis Iakovou; Eugenia Nikolsky; Eve D. Aymong; Gary S. Mintz; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Impact of nephropathy after percutaneous

✍ Beth A Bartholomew; Kishore J Harjai; Srinivas Dukkipati; Judith A Boura; Michae 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 137 KB